参考文献/References:
[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.[2]Maguire PJ,Sobota A,Mulholland D,et al.Incidence, management, and sequelae of ureteric obstruction in women with cervical cancer[J].Support Care Cancer,2020,28(2):725-730.[3]Yang YR,Chen SJ,Yen PY,et al.Hydronephrosis in patients with cervical cancer is an indicator of poor outcome: A nationwide population-based retrospective cohort study[J].Medicine (Baltimore),2021,100(6):e24182.[4]黄小平,李开林,丁苇,等.超声引导经皮肾盂造瘘治疗恶性肿瘤所致梗阻性肾功能衰竭[J].现代临床医学,2016,42(3):193-194. [5]Kim JW,Hong B,Shin JH,et al.A Prospective Randomized Comparison of a Covered Metallic Ureteral Stent and a Double-J Stent for Malignant Ureteral Obstruction[J].Korean J Radiol,2018,19(4):606-612.[6]Alma E,Ercil H,Vuruskan E,et al.Long-term follow-up results and complications in cancer patients with persistent nephrostomy due to malignant ureteral obstruction[J].Support Care Cancer,2020,28(11):5581-5588.[7]Tan S,Tao Z,Bian X,et al.Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer[J].Eur J Obstet Gynecol Reprod Biol,2019,241:99-103.[8]郭恒辉,陈国伟,刘强,等.金属支架置入术治疗恶性肿瘤性输尿管梗阻疗效及对生活质量的影响[J].新疆医学,2017,47(11):1297-1298.[9]Wang JY,Zhang HL,Zhu Y,et al.Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients[J].Oncol Lett,2016,11(1):879-883.[10]Noegroho BS,Mustafa A.Predictive factor for successful retrograde ureteral stent insertion in obstructive uropathy due to advanced cervical cancer[J].Urogynaecologia International Journal,2019,31(1).[11]张鸿毅,崔洁,高继学,等.膀胱镜下置管术及肾造瘘术处理宫颈癌所致肾积水的疗效和影响因素分析[J].临床泌尿外科杂志,2017,32(4):298-302.[12]Song Y,Fei X,Song Y.Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies[J].Int J Gynecol Cancer,2012,22(4):697-702.[13]Santosa KB,Prawira MM,Pramana IBP,et al.Predictor of successful dj stent insertion in advanced cervical cancer[J].Open Access Macedonian Journal of Medical Sciences,2020,8(b)(B):882-886.[14]Rose PG,Ali S,Whitney CW,et al.Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study[J].Gynecol Oncol,2010,117(2):270-275.[15]Goklu MR,Seckin KD,Togrul C,et al.Effect of hydronephrosis on survival in advanced stage cervical cancer[J].Asian Pac J Cancer Prev,2015,16(10):4219-4222.[16]Chan SY,Matsuda T.Endourology Progress Technique, technology and training: Technique, technology and training[DB/OL].https://www.researchgate.net/publication/345467854_Endourology_Progress_Technique_technology_and_training_Technique_technology_and_training,2019-01-01/2021-02-02.[17]Jeong IG,Han KS,Joung JY,et al.The outcome with ureteric stents for managing non-urological malignant ureteric obstruction[J].BJU Int,2007,100(6):1288-1291.[18]Kanou T,Fujiyama C,Nishimura K,et al.Management of extrinsic malignant ureteral obstruction with urinary diversion[J].Int J Urol,2007,14(8):689-692.[19]Smyth R,Mulholland D,Courtney M,et al.Retrograde ureteric stent exchange in the female oncology patient by interventional radiology: the experience of a single tertiary referral centre[J].Ir J Med Sci,2020,189(3):1097-1104.[20]Chung SY,Stein RJ,Landsittel D,et al.15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents[J].J Urol,2004,172(2):592-595.[21]Liu YM,Ni LQ,Wang SS,et al.Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study[J].World J Surg Oncol,2018,16(1):18.[22]Schmidbauer J,Remzi M,Klingler C,et al.Palliative urinary diversion by Subcutaneous NEPHRO-VESICAL /NEPHRO-CUTANEOUS bypass in END-STAGE Malignant Disease[J].Journal of Urology,2009,181(4):286.
相似文献/References:
[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(09):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(09):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[4]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(09):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[5]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(09):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[6]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,31(09):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[7]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者
分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Medical Information,2018,31(09):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
[8]吴晓玲,周桂华.miR-187在宫颈癌中的表达与临床病理关系的研究[J].医学信息,2018,31(16):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
WU Xiao-ling,ZHOU Gui-hua.Expression of miR-187 in Cervical Cancer and Its Relationship with Clinicopathological Features[J].Medical Information,2018,31(09):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
[9]夏为书,彭莉贞,钟清玲.我国宫颈癌患者配偶生活质量评价的研究现状[J].医学信息,2018,31(23):41.[doi:10.3969/j.issn.1006-1959.2018.23.012]
XIA Wei-shu,PENG Li-zhen,ZHONG Qing-ling.Research Status of Spouse Quality of Life Evaluation of Cervical Cancer Patients in China[J].Medical Information,2018,31(09):41.[doi:10.3969/j.issn.1006-1959.2018.23.012]
[10]邢 均.全身麻醉联合硬膜外麻醉在宫颈癌手术中的应用及效果评价[J].医学信息,2019,32(01):122.[doi:10.3969/j.issn.1006-1959.2019.01.037]
XING Jun.Application and Evaluation of General Anesthesia Combined with Epidural Anesthesia in[J].Medical Information,2019,32(09):122.[doi:10.3969/j.issn.1006-1959.2019.01.037]